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Abstract 
Purpose. This study examined the effect of an acute bout of brisk walking on appetite, 
energy intake and the appetite stimulating hormone - acylated ghrelin. Methods. Fourteen 
healthy young males (age 21.9 ± 0.5 years, BMI 23.4 ± 0.5 kg.m
-2
 , VO2 max 55.9 ± 0.7 
mL.kg
-1
.min
-1
) completed two eight hour trials (brisk walking and control) in a randomized-
counterbalanced fashion. The brisk walking trial commenced with 60 minutes of subjectively 
paced brisk walking on a level motorised treadmill after which participants rested for seven 
hours. Participants rested for the duration of the control trial.  Ad Libitum buffet meals were 
offered twice during main trials (1.5-2 and 5-5.5 h). Appetite (hunger, fullness, satisfaction 
and prospective food consumption) was assessed at 30 minute intervals throughout. Acylated 
ghrelin, glucose, insulin and triacylglycerol were determined from plasma. Results. Sixty 
minutes of brisk walking (7.0 ± 0.1 km.hr
-1
)
 
yielded a net (exercise minus resting) energy 
expenditure of 2008 ± 134 kJ yet did not significantly influence appetite, 
energy/macronutrient intake or the plasma concentration of acylated ghrelin, either during or 
after exercise (P > 0.05). Participants did not compensate for energy expended during 
walking therefore a deficit in energy was induced (1836 kJ, 439 kcal) relative to control. 
Conclusion. This study demonstrates that despite inducing a moderate energy deficit, an 
acute bout of subjectively paced brisk walking does not elicit compensatory responses in 
acylated ghrelin, appetite or energy intake. This finding lends support for a role of brisk 
walking in weight management. 
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Introduction 
Paragraph Number 1. Walking can provide many health benefits lessening the risk of a 
range of chronic health conditions, particularly those relating to cardiovascular disease and 
type 2 diabetes mellitus (31, 7,  28). Less clear  is the influence of walking on energy balance 
and weight control (31). This is concerning given the rising global prevalence of overweight 
and obesity (20). Enhancing levels of physical activity within the population has been 
highlighted as important in combating present trends (12) and as walking is the most popular 
modality of physical activity undertaken on this scale a definitive understanding of its 
influence on energy balance and weight control is necessary. 
 
Paragraph Number 2. Consistent with any form of physical exertion walking induces the 
expenditure of energy. Therefore, if performed frequently, walking should make an important 
contribution to successful energy balance. This account may be too simplistic however as the 
consensus of evidence fails to demonstrate a consistent effect of walking on indices of weight 
control (31). Compensatory responses following exercise may be implicit in this regard (23). 
In particular, it is possible that an augmentation of appetite and energy intake may occur 
following the expenditure of energy through physical activity (23). It is foreseeable that an 
increase in energy intake following exercise could negate the energy expended during an 
acute bout of walking. Variability in appetite and energy intake responses after both discrete 
and chronic episodes of walking may explain the inconsistent findings reported previously 
(31). 
 
Paragraph Number 3. Studies examining the effect of exercise on both appetite and energy 
intake typically demonstrate a lack of influence in the short-term (2). Studies examining the 
specific influence of walking on appetite (19) and energy intake (19, 18, 33) typically 
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confirm this finding although one study has found a suppression of hunger following 20 
minutes of brisk walking (39). 
 
Paragraph Number 4. The regulation of appetite and energy intake is under complex 
neuroendocrine control involving both centrally and peripherally mediated systems (32). Gut 
peptides within the enteric endocrine system are integral to this process and efforts seeking to 
define how these peptides respond to exercise have recently begun (26, 29). Of the gut 
peptides regulating energy homeostasis ghrelin remains unique as the only known circulating 
orexigen (25). The influence of acute exercise on plasma total ghrelin is contentious however 
as studies have reported no change in ghrelin during or following exercise (6, 27) in addition 
to both increases (8, 15, 34) and decreases (38, 40). Acylation of ghrelin is thought to be 
essential for appetite regulation, therefore assessment of total ghrelin may mask important 
changes in acylated ghrelin. Indeed, following a cycling stimulus, Marzullo and co-workers 
(30) recently found no change in plasma concentrations of total ghrelin despite acylated 
ghrelin being suppressed. Furthermore, concomitant suppressions of acylated ghrelin and 
hunger have been reported following high intensity bouts of running and resistance exercise 
(4, 5). Despite this, how acylated ghrelin responds to low intensity exercise such as walking 
remains unknown. In addition to this, the question of whether exercise-induced changes in 
acylated ghrelin have implications for actual food intake is yet to receive attention. 
 
Paragraph Number 5. The purpose of the present study was to examine the appetite, energy 
intake and the plasma acylated ghrelin response for an extended period of time after an acute 
bout of exercise. Specifically, the response of these variables during and for several hours 
after a 60 minute bout of brisk walking was examined. We sought to assess both the 
immediate and prolonged influence of walking on acylated ghrelin, appetite and energy 
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intake. The findings reported here may have implications concerning the promotion of 
walking for successful weight control. 
 
Methods 
Paragraph Number 6. Participants. Following ethical advisory committee approval 
fourteen healthy males (18-26 years) gave their written informed consent to participate. 
Participants were non-smokers, had no known history of cardiovascular/metabolic disease, 
were not dieting or taking medication and were not obese (BMI ≤ 29.9 kg.m2) or 
hypertensive (resting blood pressure <140/90 mmHg). Table 1 details the participant 
characteristics. 
Insert Table 1 here 
 
Paragraph Number 7. Screening and Familiarisation. Before partaking in main trials 
participants visited the laboratory to undergo screening, familiarisation and preliminary 
anthropometric and exercise testing. Questionnaires were completed to assess health status, 
physical activity habits and food preferences. Height was measured to the nearest 0.1 cm 
using a stadiometer (Seca Ltd, Germany) and body weight was measured to the nearest 0.01 
kg using a balance beam scale (Avery Industrial Ltd., Leicester, U.K.). Body mass index 
(BMI) was then calculated. Waist circumference was determined as the narrowest part of the 
torso (above the umbilicus and below the xiphoid process). Body density was estimated via 
subcutaneous fat measurements (13) made using skinfold callipers (Baty International, West 
Sussex, UK) and body fat percentage was ascertained (35). 
 
Paragraph Number 8. Exercise Tests. A submaximal treadmill walking test was completed 
on a level motorised treadmill to ascertain each participant‟s subjective brisk walking speed. 
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Participants were told that brisk walking was defined as an exercise intensity yielding a mild 
shortening of breath yet still enabling the individual to converse. During the test the treadmill 
speed was initially adjusted until a suitable pace was determined. Participants then 
maintained this speed for five minutes. In the final minute of the test heart rate was measured 
using short-range telemetry (Sports tester PE3000, Polar Electro, Finland) and ratings of 
perceived exertion (RPE) were recorded (3). After sufficient rest maximum oxygen uptake 
was assessed via an incremental treadmill run to exhaustion on a level motorised treadmill 
(36). One minute samples of expired air were collected in the final minute of each stage. 
Final collections were taken when participants could continue for one minute only.  
 
Paragraph Number 9. Main Trials. Participants completed two main trials (brisk walking 
and control) in a randomized-counterbalanced fashion. Trials were separated by at least one 
week. Participants began main trials in the fasted state having consumed only water since 
11:00 pm on the evening immediately prior to main trials. Each trial commenced between 
09:00-09:30 am and lasted 8 h. On trial days participants travelled to the laboratory via 
motorised transport however if this was not possible it was ensured that any exertion prior to 
trials was minimal. The brisk walking trial commenced with a 60 minute subjectively paced 
brisk walk on a level motorised treadmill (Runrace, Technogym, Gambettola, Italy). The 
initial walking pace was that ascertained in the preliminary laboratory visit although 
adjustments were made if discomfort was experienced. Samples of expired air were collected 
at 15 minute intervals throughout to determine energy expenditure and substrate oxidation 
(17). Heart rate and RPE were also assessed at these times. Following the walk participants 
rested for 7 h (sitting reading, writing, working at a computer or watching television). 
Participants rested for the entire duration of the control trial. In order to estimate the net 
energy expenditure of brisk walking (gross energy expenditure of walking minus resting 
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energy expenditure), samples of expired air were collected in the semi-supine position during 
the first hour of the control trial to estimate resting metabolic rate. At baseline, 0.5 h, 1 h and 
at 30 minute intervals thereafter, ratings of appetite (hunger, satisfaction, fullness and 
prospective food consumption) were assessed using 100 mm visual analogue scales (16). 
Environmental temperature and humidity were also measured at these times using a handheld 
hygrometer (Omega RH85, Manchester, UK). Figure 1 provides an overview of the protocol 
for the main trials. Further details of these trials are given in the paragraphs below. 
 
Insert Figure 1 here 
 
Paragraph Number 10. Ad Libitum Buffet Meals. During main trials participants consumed 
food from an ad libitum buffet meal provided twice throughout (1.5-2 h and 5-5.5 h). The 
buffet foods were identical prior to each meal (Appendix A) and provided diversity in 
protein, fat and carbohydrate content in order to facilitate the detection of macronutrient 
preferences. Food was presented in excess of expected consumption. Participants were told to 
eat until satisfied and that additional food was available if desired. Participants consumed 
meals in isolation so that social influence did not constrain food selection. Food consumption 
was ascertained by weighing buffet items before and after each meal. The energy and 
macronutrient content of the items consumed was ascertained using manufacturer values. 
Prior to main trials acceptability of the buffet food items presented was ensured after 
completion of a food preference questionnaire. The questionnaire required participants to rate 
pre-selected food items on a scale ranging from one (dislike extremely) to ten (like 
extremely). Questionnaires were examined to ensure that the food items available would be to 
the taste of each individual. Distaste for the buffet items (rating 4 items ≤ 4) resulted in 
participant non-inclusion. 
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Paragraph Number 11. Physical Activity and Dietary Standardization. Participants 
completed a weighed food record of all items consumed within the 24 h preceding their first 
main trial. Alcohol and caffeine were not permitted during this period. This feeding pattern 
was replicated prior to subsequent trials. Participants also refrained from strenuous physical 
activity during this time. 
 
Paragraph Number 12. Blood Sampling. A cannula (Venflon, Becton Dickinson, 
Helsinborg, Sweden) was inserted into an antecubital or a forearm vein while participants lay 
in a semi-supine position ~30 minutes before main trials commenced. Venous blood samples 
were taken into pre-chilled 4.9 mL monovettes (Sarstedt, Leicester, UK)  at baseline, 0.5, 1, 
1.5, 2, 2.5, 5, 5.5, 6, 7, and 8 h to measure plasma acylated ghrelin. To prevent the 
degradation of acylated ghrelin by protease these monovettes contained EDTA and a 50 µL 
solution containing potassium phosphate buffer (0.1 M), P-hydroxymercuribenzoic acid (100 
mM) and sodium hydroxide (10 M). Monovettes were spun at 1,287g for 10 minutes in a 
refrigerated centrifuge at 4
 o
C. The plasma supernatant was then dispensed into a storage tube 
and 100 µL of hydrochloric acid (1 M) was added per millilitre of plasma. Thereafter, 
samples were spun at 1,287g for 5 minutes in a refrigerated centrifuge prior to storage. 
Additional blood samples were collected into pre-chilled 9 mL EDTA monovettes (Sarstedt, 
Leicester, UK) at baseline, 0.5, 1, 1.5, 2, 2.25, 2.5, 3, 3.5, 5, 5.5, 5.75, 6, 6.5, 7 and 8 h for the 
determination of plasma glucose and triacylglycerol. Plasma insulin was determined from 
collections at 0, 1, 1.5, 2, 2.25, 2.5, 3.5, 5, 5.5, 5.75, 6, 7 and 8 h. These monovettes were 
spun at 1,681g for 10 minutes in a refrigerated centrifuge (Bukard, Hertfordshire, U.K.) at 4
 
o
C. The plasma supernatant was then aliquoted into 2 mL Eppendorf tubes prior to storage for 
analysis later. 
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Paragraph Number 13. All blood samples were taken in the semi-supine position except for 
0.5 h collections during the brisk walking trial where subjects straddled the treadmill. To 
avoid sample dilution residual saline was discarded using a 2 mL syringe prior to each 
collection. Patency of the cannula was maintained by flushing with non-heparinised saline 
(0.9 % w/v Sodium Chloride, Baxter Healthcare Ltd., Norfolk, U.K.). To estimates changes 
in plasma volume (11) duplicate 20 µL blood samples were collected into micropipettes and 
triplicate 20 μL samples were collected into heparinised microhaematocrit tubes to determine 
blood haemoglobin and haematocrit concentrations respectively. 
 
Paragraph Number 14. Biochemical Analysis. Enzyme immunoassays were used to 
determine concentrations of plasma acylated ghrelin (SPI BIO, Montigny le Bretonneux, 
France) and insulin (Mercodia, Uppsala, Sweden) with the aid of a plate reader (Expert Plus, 
ASYS Atlantis, Eugendorf, Austria). Plasma glucose and triacylglycerol concentrations were 
determined spectrophotometrically using a bench top analyzer (Pentra 400, HORIBA ABX 
Diagnostics, Montpellier, France). To eliminate inter-assay variation, samples from each 
participant were analyzed in the same run. The within batch coefficients of variation for the 
assays were as follows: acylated ghrelin 7.8%, insulin 6.3%, glucose 0.4% and triacylglycerol 
2.7%. 
 
Paragraph Number 15. Statistical Analysis. Data was analyzed using the Statistical Package 
for the social Sciences (SPSS) software version 14.0 for Windows (SPSS Inc, Chicago, IL, 
U.S.). Area under the concentration verses time curve calculations were performed using the 
trapezoidal method. Student‟s t-tests for correlated data were used to assess differences 
between fasting and area under the curve values for acylated ghrelin, glucose, insulin, 
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triacylglycerol, temperature, humidity and appetite between the control and brisk walking 
trials. Repeated measures, two-factor ANOVA was used to examine differences between the 
walking and control trials over time for body mass, appetite, energy and macronutrient intake, 
acylated ghrelin, glucose, insulin and triacylglycerol. The Pearson product moment 
correlation coefficient was used to examine relationships between variables. Correction of 
values for changes in plasma volume did not alter the statistical significance of findings 
therefore for simplicity the unadjusted values are presented. Statistical significance was 
accepted at the 5% level. Results are presented as mean ± SEM. 
 
Results 
Paragraph Number 16. Brisk walking responses. Participants completed the 60 minute brisk 
walk at 7.0 ± 0.1 km.h
-1
. This elicited a mean oxygen consumption equivalent to 45.2 ± 2%  
of VO2 max (range: 33.8 to 55.5%) and generated an average heart rate and net (exercise 
minus resting) energy expenditure of 137 ± 6 beats.min
-1 
and 2008 ± 134 kJ, respectively. A 
mean non-protein respiratory quotient of 0.89 ± 0.01 reflected the proportional contributions 
of carbohydrate and fat (61± 3% and 39 ± 3%) to energy provision. A median RPE value of 
11 indicated that the intensity of the walk was perceived as „fairly light‟ (range 10-12). 
 
Paragraph Number 17. Baseline Parameters. No between trial differences existed at 
baseline in the plasma concentrations of acylated ghrelin, glucose, insulin, or triacylglycerol. 
Appetite perceptions were also no different at baseline (Table 2).  
 
Insert Table 2 here 
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Paragraph Number 18. Appetite and Energy Intake. Two-factor ANOVA revealed a main 
effect of time (P < 0.001) but no trial or interaction (trial x time) main effects for all appetite 
perceptions assessed (hunger, satisfaction, fullness and PFC), indicating that these appetite 
perceptions changed significantly over the course of trials but were not influenced by brisk 
walking (Figure 2). Two-factor ANOVA showed no trial or interaction (trial x meal) main 
effects for energy intake (P > 0.05). Thus, energy intake was not significantly different 
between the control and brisk walking trials. Moreover, energy intake was also no different 
between the morning meal and the afternoon meal during the control and brisk walking trials 
(Table 3). Examination of the relative energy intake (energy intake – (walking energy 
expenditure – resting energy expenditure)) showed that energy consumption was significantly 
reduced in the brisk walking trial compared to the control trial (P < 0.001). After adjusting 
for the energy expenditure of walking there was an energy deficit of 1836 ± 130 kJ (439 ± 31 
kcal) in the brisk walking trial compared with the control trial.  
 
Insert Figure 2 & Table 3 here 
 
Paragraph Number 19. Macronutrient Intake. Table 4 shows the energy derived from the 
macronutrients in the control and brisk walking trials. There was no significant difference 
between trials in the quantity of energy derived from fat (P = 0.396). Fat intake tended to be 
higher in the afternoon meal than the morning meal (P = 0.053) however this tendency was 
no different between trials (P = 0.495). Likewise, carbohydrate intake was no different 
between trials (P = 0.969). Neither was carbohydrate intake significantly different between 
the morning and afternoon meals (P = 0.628) in either the control or brisk walking trials (P = 
0.862). Consumption of protein was no different between trials (P = 0.358). Protein intake 
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did not differ significantly between the morning and afternoon meals (P = 0.461) in either the 
control or brisk walking trials (trial x meal interaction, P = 0.290). 
 
Insert Table 4 here 
 
Paragraph Number 20. Plasma Metabolites. Plasma acylated ghrelin concentration changed 
significantly over time (two-factor ANOVA, P = 0.003). No trial (P = 0.922) or interaction 
(trial x time, P = 0.803) main effects were found. The plasma concentration of acylated 
ghrelin was suppressed after consumption of the morning meal (1.5 – 2 h) and then rose prior 
to the afternoon meal (5 – 5.5 h) although the concentration did not reach fasting values. The 
afternoon meal also induced a suppression of plasma acylated ghrelin concentrations (Figure 
3). Two-factor ANOVA revealed a main effect of time (all P < 0.001) but no trial or 
interaction (trial x time) main effects for plasma glucose, insulin and triacylglycerol (Figure 
4). 
 
Insert Figures 3 & 4 here 
 
Paragraph Number 21. Correlations between acylated ghrelin and other variables. Fasting 
plasma acylated ghrelin concentration was not significantly correlated with body mass, BMI, 
waist circumference, body fat %, maximum oxygen uptake, fasting insulin, fasting glucose or 
fasting triacylglycerol concentration. In the brisk walking trial acylated ghrelin and 
prospective food consumption area under the curve (AUC) were positively correlated during 
the intermeal interval (1.5-5 h) (r = 0.723, P = 0.028).  In the brisk walking trial acylated 
ghrelin and plasma triacylglycerol AUC were negatively correlated during the intermeal 
interval (1.5-5 h) (r = -0.827, P = 0.006) and across the total trial (0-8 h) (r = -0.694, P = 
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0.038). Acylated ghrelin and insulin AUC values tended to be negatively correlated across 
the total trial (0-8 h) (r = -0.660, P = 0.053).  
 
Paragraph Number 22. When examining correlations at individual time points many 
significant relationships emerged. At 1 and 2 h during the control trial acylated ghrelin was 
positively correlated with hunger and prospective food consumption. Correlation coefficients 
ranged from 0.672 to 0.809. During the control trial acylated ghrelin was negatively 
correlated with fullness at 1 and 2 h, and with satisfaction at 1, 2 and 5.5 h. Correlation 
coefficients ranged from -0.716 to -0.898. Inverse relationships were observed between 
acylated ghrelin and plasma triacylglycerol at 2.5 h in the brisk walking trial (r = -0.714, P = 
0.031) and with plasma insulin at 5 h in the brisk walking trial (r = -0.744, P = 0.022). 
 
Discussion 
Paragraph Number 23. The purpose of this investigation was to examine the appetite, 
energy intake and plasma acylated ghrelin response during and for several hours following a 
60 minute bout of brisk walking. The main finding arising from this study is that despite 
inducing a moderate energy deficit an acute bout of brisk walking did not modify appetite, 
energy intake or the appetite stimulating hormone - acylated ghrelin. These findings lend 
support for a role of brisk walking in weight control. 
 
Paragraph Number 24. The finding of no difference in appetite (hunger, satiety, fullness, 
PFC) between the control and brisk walking trials is consistent with previous work which has 
failed to observe an immediate difference in appetite following an acute bout of exercise (2). 
The relatively moderate intensity of exertion and subsequent energy expenditure elicited 
through walking may explain this finding. Previous work has consistently observed a 
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suppression of appetite during and briefly following intense bouts of activity (> 60% of VO2 
max) (2). This response may therefore have been unanticipated in the present study as brisk 
walking provided a lesser physiological challenge to the relatively fit sample of participants 
examined. 
 
Paragraph Number 25. Consistent with no change in appetite, brisk walking also failed to 
influence energy intake as in both the morning and afternoon meals energy intake was highly 
congruent between trials. This observation confirms previous findings which have typically 
shown no difference in energy intake in the short term (1 – 2 days) following an acute 
exercise bout (2). Participants therefore failed to compensate for the exercise-induced energy 
expenditure. King and co-workers (22) have suggested that the relative post-exercise energy 
intake response (absolute energy intake adjusted for the net exercise induced energy 
expenditure) is of greater importance than the absolute amount of energy consumed. Using 
this formulae, in the present study brisk walking induced a relative deficit in energy in 
comparison with control (1836 kJ, 439 kcal). This finding suggests that brisk walking does 
not elicit an automatic compensation in energy intake in the immediate hours following 
exercise. Although a more delayed response remains a possibility, this initial finding lends 
support for the utility of brisk walking in successful body weight control.  
 
Paragraph Number 26. No change in macronutrient preference was detected between the 
control and brisk walking trials as in both the morning and afternoon meals the distribution of 
energy was typical of a Western diet. This observation confirms results from the majority of 
previous laboratory interventions which have failed to show any consistent effect of exercise 
on food preferences (14). In this investigation no change in macronutrient selection 
contributed to the lack of difference in energy intake observed between trials. Previous work 
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has shown that switching from low-fat to high-fat food options completely reverses the 
energy deficit induced by prior exercise (21, 24). It is therefore appealing that brisk walking 
did not stimulate an appetite for foods with a higher content of fat and therefore energy. 
 
Paragraph Number 27. To the authors‟ knowledge this study is the first to examine the 
acylated ghrelin response to brisk walking. Therefore, a novel finding is that plasma acylated 
ghrelin concentration is not affected during or for several hours after an acute bout of brisk 
walking. This finding is consistent with the lack of difference in appetite and energy intake 
observed between trials. Previously, a concomitant suppression of plasma acylated ghrelin 
and hunger has been observed during and briefly following an intense bout of treadmill 
running (4, 5). Brisk walking did not affect hunger in the present study, therefore, given the 
role of ghrelin in appetite regulation, no change in acylated ghrelin is a logical outcome. The 
reduced physiological challenge imposed by walking compared with running may account for 
the difference in findings between studies. In particular, an attenuated gut disturbance and/or 
redistribution of splanchnic blood volume during walking may be implicative. This finding 
indicates that acylated ghrelin is not sensitive to moderate deficits in energy induced via low 
intensity bouts of physical activity and holds positive implications for brisk walking in 
healthy body weight control.  
 
Paragraph Number 28. In each trial acylated ghrelin was suppressed after the consumption 
of the morning meal, rose during the intermeal interval and declined again after the afternoon 
meal. This observation confirms previous findings regarding the temporal response of ghrelin 
to feeding (9, 10). The postprandial acylated ghrelin response may be related to an increase in 
plasma insulin concentration (1). The inverse relationship observed between insulin and 
acylated ghrelin across the walking trial lends support to this hypothesis. Meals high in fat do 
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not suppress acylated ghrelin as efficaciously as those high in protein and carbohydrate (37). 
The significant inverse associations found between acylated ghrelin and triacylglycerol were 
therefore an unexpected finding in the present investigation. Further work is needed to 
illuminate the relevance of this. 
 
Paragraph Number 29. This study has two notable limitations. Firstly, the sample of 
participants was composed of a relatively homogenous population of young, healthy males 
therefore the findings may not generalize to clinical populations. The homogeneity of the 
sample may also have prevented the detection of significant relationships between important 
variables such as fasting acylated ghrelin and anthropometric parameters. Secondly, appetite, 
energy intake and acylated ghrelin responses were observed merely for several hours after 
walking. Assessment of these variables over a greater period of time may be necessary in 
order to detect any compensatory responses. 
 
Paragraph Number 30. In conclusion, this study demonstrates that an acute bout of brisk 
walking does not increase appetite, energy intake or plasma acylated ghrelin concentrations, 
despite inducing a moderate deficit in energy. This finding lends support for a role of brisk 
walking in successful weight management. Further work is now required to examine 
responses over a greater period of time and in other important populations including the 
elderly and the obese. Such findings will contribute to a greater understanding of the 
influence of walking on energy homeostasis. 
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Figure Captions 
 
Figure 1. Schematic representation of the study protocol. Plasma glucose and triacylglycerol 
were determined from additional samples at 16 time points during each trial and insulin at 13 
time points (not shown). 
 
Figure 2. Perceptions of hunger (a), satisfaction (b), fullness (c) and prospective food 
consumption (d) in the control (●) and brisk walking (○) trials. Values are mean ± SEM (n = 
14). Black rectangle indicates brisk walking – diagonally shaded rectangles indicate ad 
libitum meals. 
 
Figure 3. Plasma acylated ghrelin concentrations in the control (●) and brisk walking (○) 
trials. Values are mean ± SEM (n = 14). Black rectangle indicates brisk walking – diagonally 
shaded rectangles indicate ad libitum meals. 
 
Figure 4. Plasma concentrations of triacylglycerol (a), insulin (b) and glucose (c) in the 
control (●) and brisk walking (○) trials. Values are mean ± SEM (n = 14). Black rectangle 
indicates brisk walking – diagonally shaded rectangles indicate ad libitum meals. 
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Appendices 
 
 Appendix A: Items presented at buffet meals  
Coco-pops® - Cereal 
Cornflakes® - Cereal 
Rice Krispies® - Cereal 
Frosties® - Cereal 
Milk  
Cereal Bar 
White Bread 
Brown Bread 
Tuna 
Cheese 
Ham 
Butter 
Mayonnaise 
Salted Crisps 
Apple 
Orange 
Banana 
Chocolate rolls 
Chocolate muffins 
Plain muffins 
Cookies 
Chocolate bar (Mars fun size®) 
 
 
 
 
 
 
Table 1: Participant characteristics. Values are mean SEM (n = 14).
Characteristic
Age (yrs) 21.9 ± 0.5
BMI (kg∙m-2) 23.4 ± 0.6
Body Fat (%) 19.2 ± 1.2
Waist Circumference (cm) 81.0 ± 1.5
VO2 max (mL∙ kg
-1 ∙ min-1) 55.9 ± 1.8
Table 1
Table 2: Baseline metabolite and appetite values in the control and brisk walking trials.
Values are mean ± SEM (n = 14). PFC = Prospective food consumption.
Control Brisk Walking P
Acylated ghrelin (pg.mL-1) 81.4 ± 9.1 93.2  ± 22.3 0.507
Glucose (mmol.L-1) 4.49 ± 0.2 4.41 ± 0.2 0.520
Insulin (pmol.L-1) 27.5 ± 5.2 30.1 ± 5.0 0.671
Triacylglycerol (mmol.L-1) 0.82 ± 0.1 0.78 ± 0.1 0.462
Hunger (0-100) 55 ± 7 58 ± 6 0.718
Satisfaction (0-100) 29 ± 7 29 ± 6 0.972
Fullness (0-100) 29 ± 7 27 ± 6 0.647
PFC (0-100) 65 ± 7 71 ± 6 0.290
Table 2
Table 3: Energy intake during the control and brisk walking trials. Values are mean ± SEM (n = 14).
Values presented are kJ and (kcal).
Control Brisk Walking
Morning meal (1.5-2 hours) 4483 ± 378
(1072 ± 90)
4520 ± 436
(1080 ± 104)
Afternoon Meal (5-5.5 hours) 4729 ± 348
(1130 ± 83)
4864 ± 490
(1163 ± 117)
Total Trial 9212 ± 588
(2202 ± 141)
9384 ± 659
(2243 ± 157)
Table 3
Table 4: Energy derived from the macronutrients during the ad libitum buffet meals in the control (upper panel)
and brisk walking (lower panel) trials. Values are mean ± SEM (n = 14).  Values presented are grams and (%).
Control Fat Carbohydrate Protein
Morning Meal (1.5-2 hrs) 37.7 ± 4.9
(31.7)
143.5 ± 8.3
(53.6)
39.5 ± 8.8
(14.7)
Afternoon Meal (5-5.5 hrs) 45.5 ± 4.5
(36.2)
137.2 ± 16.2
(48.5)
43.1 ± 7.4
(15.3)
Total Trial 83.2 ± 7.9
(34.0)
280.7 ± 20.4
(51.0)
82.6 ± 14.8
(15.0)
Brisk Walking Fat Carbohydrate Protein
Morning Meal (1.5-2 hrs) 35.3 ± 4.4
(29.4)
149.0 ± 13.5
(55.2)
41.7 ± 8.8
(15.4)
Afternoon Meal (5-5.5 hrs) 44.2 ± 5.6
(34.2)
141.2 ± 13.9
(48.6)
50.1 ± 10.2
(17.2)
Total Trial 79.5 ± 8.1
(31.9)
290.2 ± 19.4
(51.7)
91.8 ± 15.5
(16.4)
Table 4
Baseline
(09:00)
1
(10:00)
2
(11:00)
3
(12:00)
4
(13:00)
5
(14:00)
6
(15:00)
7
(16:00)
8
(17:00)
Ad libitum buffet meals
Plasma acylated ghrelin sample
Appetite measurement
Brisk Walk
Time in hours (approximate time of day)
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